We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clover Biopharmaceuticals Touts Positive Phase 1 Data for COVID-19 Vaccine
Clover Biopharmaceuticals Touts Positive Phase 1 Data for COVID-19 Vaccine
China’s Clover Biopharmaceuticals has announced its COVID-19 S Trimer vaccine candidate delivered a “strong immune response” in 150 adult and elderly phase 1 trial participants, with pre-publication results to be released soon.